Home / Latest Science News -- ScienceDaily / New screening process could lead to next-generation therapeutics for a broad spectrum of diseases

New screening process could lead to next-generation therapeutics for a broad spectrum of diseases

Researchers have developed a high-throughput screen methodology to identify compounds affect a key G protein coupled receptor (GPCR) rhodopsin (Rh). GPCRs mediate many important physiological functions and are considered to be one of the most effective therapeutic targets for a broad spectrum of diseases, ranging from diabetes to immune system disorders.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/11/211116175028.htm
New screening process could lead to next-generation therapeutics for a broad spectrum of diseases New screening process could lead to next-generation therapeutics for a broad spectrum of diseases Reviewed by cmakigo on November 17, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.